Eporgen - Nurturing the winners
Eporgen is the first Italian company, entirely funded by private, non-institutional investors, which is dedicated to seed capital investments in the area of life sciences.
Eporgen, portfolio, start-up, patents, bio, financing, pharma, research, academic institutions, proof-of-concept, candiolo, tumour, peptides, hepatic tumors, endometriosis, anti-cancer, drug, Hepatoma Derived Growth Factors, HDGF, vaccines, chronic diseases, renal, prostate, lu
Is this your site? Certify your site and update informations
